Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

cadila-pharma

Tag: cadila pharma

Read all Latest developments, information and news on and about Cadila-pharma - Page 3

Cadila pharma, a leading Indian pharma company is a fully integrated, global healthcare provider. From formulations to active pharma ingredients, expertise in all. - Latest News and Updates

NPPA fixes retail prices of 37 formulations, including Sitagliptin- Metformin combinations

Ruchika Sharma17 Sept 2022 6:00 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 37 formulations including those...

Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations

Ruchika Sharma25 Aug 2022 5:00 PM IST

New Delhi: Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...

53 Drug Samples Fail To Clear CDSCO Test, 1 Declared Misbranded

Susmita Roy12 Aug 2022 6:00 PM IST

New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 53 medicine...

Cadila Pharma launches Bempedoic acid under brand name Belmore to treat bad cholesterol

Ruchika Sharma25 May 2022 12:29 PM IST

As per published data, more than 30 percent of adults in urban areas and 20 percent in rural areas in the country are suffering from the heart...

Drug alert: CDSCO flags 48 drugs as not of standard quality

Susmita Roy28 April 2022 6:54 PM IST

New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 48 medicine...

Cadila Pharma unveils three-dose rabies vaccine ThRabis

Roshni Dhar12 April 2022 3:07 PM IST

Pharmaceutical major Cadila Pharmaceuticals on Friday announced that it has developed the world's first novel three-dose vaccine against rabies.The...

Health Bulletin 11/April/2022

Roshni Dhar11 April 2022 5:25 PM IST

Here are the top health stories for the day: NCDRC exonerates Apollo hospital doctors, holds no negligence in treating patient with viral...

FIRST: Cadila Pharma launches three-dose rabies vaccine ThRabis

Ruchika Sharma9 April 2022 2:14 PM IST

The company has fixed the price of one vial at Rs 750 while the cost of treatment, comprising three doses, would come to Rs 2,145, it added.

NPPA fixes retail price of 47 formulations, Details

Medical Dialogues Team2 Dec 2021 4:07 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...

Intas secures CDSCO panel nod to study arthritis drug Adalimumab

Medical Dialogues Team24 Sept 2021 5:08 PM IST

New Delhi: In a significant development, drug firm Intas has got a green signal from the Subject Expert Committee (SEC) functional under the Central...

NPPA fixes retail price of Vitamin D3 strips marketed by Cadila Pharma

Medical Dialogues Team22 Sept 2021 12:16 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...

Cadila Healthcare gets CDSCO panel okay for Fluticasone Furoate, Oxymetazoline HCL nasal spray

Medical Dialogues Team19 July 2021 1:00 PM IST

New Delhi: In a major rejoice for pharma major Cadila Healthcare, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok